{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT06526078",
            "orgStudyIdInfo": {
                "id": "STUDY23110120"
            },
            "secondaryIdInfos": [
                {
                    "id": "R01MH136179",
                    "type": "NIH",
                    "link": "https://reporter.nih.gov/quickSearch/R01MH136179"
                },
                {
                    "id": "R01MH136178",
                    "type": "NIH",
                    "link": "https://reporter.nih.gov/quickSearch/R01MH136178"
                }
            ],
            "organization": {
                "fullName": "University of Pittsburgh",
                "class": "OTHER"
            },
            "briefTitle": "Cognitive Training as an Adjunct to Ketamine in Real-world Clinics",
            "officialTitle": "A Brief Automated Neurocognitive Training to Enhance the Real-World Impact of Ketamine's Rapid Antidepressant Effect",
            "therapeuticArea": [
                "Mental Health"
            ],
            "study": "cognitive-training-as-an-adjunct-to-ketamine-in-real-world-clinics"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-07",
            "overallStatus": "NOT_YET_RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2024-11-01",
                "type": "ESTIMATED"
            },
            "primaryCompletionDateStruct": {
                "date": "2029-06-01",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2030-06-01",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2024-07-22",
            "studyFirstSubmitQcDate": "2024-07-24",
            "studyFirstPostDateStruct": {
                "date": "2024-07-29",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-07-24",
            "lastUpdatePostDateStruct": {
                "date": "2024-07-29",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "PRINCIPAL_INVESTIGATOR",
                "investigatorFullName": "Rebecca Price",
                "investigatorTitle": "Associate Professor of Psychiatry and Psychology",
                "investigatorAffiliation": "University of Pittsburgh"
            },
            "leadSponsor": {
                "name": "University of Pittsburgh",
                "class": "OTHER"
            },
            "collaborators": [
                {
                    "name": "National Institute of Mental Health (NIMH)",
                    "class": "NIH"
                }
            ]
        },
        "oversightModule": {
            "oversightHasDmc": true,
            "isFdaRegulatedDrug": false,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "In a sample of patients already receiving ketamine treatment as part of their clinical care, this project seeks to test whether we can enhance and/or extend ketamine's rapid effects by introducing helpful information delivered by a computer-based cognitive training protocol. This work could ultimately lead to the ability to treat depression more efficiently and with broader dissemination by rapidly priming the brain for helpful forms of learning."
        },
        "conditionsModule": {
            "conditions": [
                "Depression"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "NA"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "PARALLEL",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "QUADRUPLE",
                    "whoMasked": [
                        "PARTICIPANT",
                        "CARE_PROVIDER",
                        "INVESTIGATOR",
                        "OUTCOMES_ASSESSOR"
                    ]
                }
            },
            "enrollmentInfo": {
                "count": 600,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Cognitive Training",
                    "type": "EXPERIMENTAL",
                    "description": "Web-based cognitive training",
                    "interventionNames": [
                        "Behavioral: Cognitive Training"
                    ]
                },
                {
                    "label": "Sham Training",
                    "type": "SHAM_COMPARATOR",
                    "description": "Web-based sham training",
                    "interventionNames": [
                        "Behavioral: Sham Training"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "BEHAVIORAL",
                    "name": "Cognitive Training",
                    "description": "Sessions of cognitive training exercises (15-20min each) self-administered via a web app",
                    "armGroupLabels": [
                        "Cognitive Training"
                    ]
                },
                {
                    "type": "BEHAVIORAL",
                    "name": "Sham Training",
                    "description": "Sessions of sham training exercises (15-20min each) self-administered via a web app",
                    "armGroupLabels": [
                        "Sham Training"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Montgomery Asberg Depression Rating Scale: During Ketamine Induction",
                    "description": "depression severity; range 0-60; high score=worse outcome",
                    "timeFrame": "Trajectories from baseline through end of 'induction phase' infusions (up to max of 12 weeks)"
                },
                {
                    "measure": "Montgomery Asberg Depression Rating Scale: After Ketamine Induction",
                    "description": "depression severity; range 0-60; high score=worse outcome",
                    "timeFrame": "Trajectories from final 'induction phase' infusion through 4 weeks post-induction"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Quick Inventory of Depressive Symptoms",
                    "description": "Self-reported depression (range: 0-27; higher scores = worse outcome)",
                    "timeFrame": "Trajectories from baseline through 12 months post-induction"
                },
                {
                    "measure": "PROMIS Measures-depression",
                    "description": "Patient-Reported Outcomes Measurement Information System (PROMIS) measure: Self-reported depression T-score range: 0-100 (higher score = worse outcome)",
                    "timeFrame": "Trajectories from baseline through 12 months post-induction"
                },
                {
                    "measure": "Beck Hopelessness Scale",
                    "description": "self reported to measure key aspects of hopelessness; range = 0-20, higher score=worse outcome",
                    "timeFrame": "Trajectories from baseline through 12 months post-induction"
                },
                {
                    "measure": "PROMIS Measures-anxiety",
                    "description": "Patient-Reported Outcomes Measurement Information System (PROMIS) measure: Self-reported anxiety T-score range: 0-100 (higher score = worse outcome)",
                    "timeFrame": "Trajectories from baseline through 12 months post-induction"
                },
                {
                    "measure": "PROMIS Measures-anger",
                    "description": "Patient-Reported Outcomes Measurement Information System (PROMIS) measure: Self-reported anger T-score range: 0-100 (higher score = worse outcome)",
                    "timeFrame": "Trajectories from baseline through 12 months post-induction"
                },
                {
                    "measure": "PROMIS Measures-Positive Affect",
                    "description": "Patient-Reported Outcomes Measurement Information System (PROMIS) measure: Self-reported positive affect/well-being T-score range: 0-100 (higher score = better outcome)",
                    "timeFrame": "Trajectories from baseline through 12 months post-induction"
                },
                {
                    "measure": "PROMIS Measures-Sleep Disturbance",
                    "description": "Patient-Reported Outcomes Measurement Information System (PROMIS) measure: Self-reported sleep disturbance T-score range: 0-100 (higher score = worse outcome)",
                    "timeFrame": "Trajectories from baseline through 12 months post-induction"
                },
                {
                    "measure": "PROMIS Measures-Cognitive Function",
                    "description": "Patient-Reported Outcomes Measurement Information System (PROMIS) measure: Self-reported cognitive function T-score range: 0-100 (higher score = better outcome)",
                    "timeFrame": "Trajectories from baseline through 12 months post-induction"
                },
                {
                    "measure": "Cognitive Triad Inventory",
                    "description": "Negative perceptions of self, future, \\& world (range=36-252; higher score = better outcome)",
                    "timeFrame": "Trajectories from baseline through 12 months post-induction"
                },
                {
                    "measure": "Montgomery Asberg Depression Rating Scale: Naturalistic Follow-up",
                    "description": "depression severity; range 0-60; high score=worse outcome",
                    "timeFrame": "Trajectories from baseline through 12 months post-induction"
                }
            ],
            "otherOutcomes": [
                {
                    "measure": "Implicit Association Test",
                    "description": "performance-based \"target engagement\" measure of implicit self-esteem; range = -inf-inf; high score=worse outcome",
                    "timeFrame": "Trajectories from baseline through 4 weeks post-infusions"
                },
                {
                    "measure": "Columbia Suicide Severity Rating Scale--Intensity of Most Severe Ideation",
                    "description": "suicidal ideation/thoughts; range 0-5; high score=worse outcome",
                    "timeFrame": "Trajectories from baseline through 12 months post-induction"
                },
                {
                    "measure": "Patient Health Care Utilization Survey (PHCUS)",
                    "description": "interview measure of psychiatric and healthcare service utilization",
                    "timeFrame": "Trajectories from baseline through 12 months post-induction"
                },
                {
                    "measure": "PROMIS Measures-substance Use",
                    "description": "Patient-Reported Outcomes Measurement Information System (PROMIS) measure: Self-reported substance use Raw score range: 0-35 (higher score = worse outcome)",
                    "timeFrame": "Trajectories from baseline through 12 months post-induction"
                },
                {
                    "measure": "PROMIS Measures-alcohol",
                    "description": "Patient-Reported Outcomes Measurement Information System (PROMIS) measure: Self-reported alcohol use T-score range: 0-100 (higher score = worse outcome)",
                    "timeFrame": "Trajectories from baseline through 12 months post-induction"
                },
                {
                    "measure": "Acceptability, Appropriateness, and Feasibility",
                    "description": "self-report scales of intervention acceptability, appropriateness, feasibility; range = 5-20; high score=better rating",
                    "timeFrame": "Post-CT assessment (approximately 5 days post infusion)"
                },
                {
                    "measure": "Short Form Health Survey",
                    "description": "Self-report measure of Quality-Adjusted Life-Years (QALYs)",
                    "timeFrame": "Baseline through 12 months post-induction"
                },
                {
                    "measure": "Client Satisfaction Questionnaire (CSQ-8)",
                    "description": "Self-reported satisfaction; range: 8-32; high score=better rating",
                    "timeFrame": "Post-CT assessment (approximately 5 days post infusion)"
                },
                {
                    "measure": "mHealth App Usability Questionnaire (MAUQ)",
                    "description": "Self-reported usability of cognitive training web app; range = 18-126; high score=better rating",
                    "timeFrame": "12 months post-induction"
                },
                {
                    "measure": "Qualitative interviews assessing implementation",
                    "description": "Custom qualitative interviews with qualitative coding",
                    "timeFrame": "12 months post-induction"
                },
                {
                    "measure": "Compliance with prescribed cognitive training sessions",
                    "description": "Compliance data from web app logs",
                    "timeFrame": "Post-CT timepoint (approximately 5 days post infusion)"
                },
                {
                    "measure": "PROMIS Measures-Social Functioning",
                    "description": "Patient-Reported Outcomes Measurement Information System (PROMIS) measures of social functioning: T-score range: 0-100 (higher score = better outcome)",
                    "timeFrame": "Trajectories from baseline through 12 months post-induction"
                },
                {
                    "measure": "PROMIS Measures-Pain",
                    "description": "Patient-Reported Outcomes Measurement Information System (PROMIS) measures of pain: T-score range: 0-100 (higher score = better outcome)",
                    "timeFrame": "Trajectories from baseline through 12 months post-induction"
                },
                {
                    "measure": "Awe Experience Scale (AWE-S)",
                    "description": "self-report measure of awe-inspiring experiences (range: 30-210; higher score=greater awe)",
                    "timeFrame": "24 hours post-infusion"
                },
                {
                    "measure": "Implicit Association Test across follow-up",
                    "description": "performance-based \"target engagement\" measure of implicit self-esteem; range = -inf-inf; high score=worse outcome",
                    "timeFrame": "Trajectories through 12 months post-induction"
                },
                {
                    "measure": "Time to relapse",
                    "description": "Time-to-event for relapse to within 25% of baseline MADRS score",
                    "timeFrame": "Baseline through 12 months post-induction"
                },
                {
                    "measure": "Time to first maintenance infusion",
                    "description": "Time-to-event for the date of return to clinic for first maintenance infusion",
                    "timeFrame": "Baseline through 12 months post-induction"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n1. be between the ages of 18 and 80 years\n2. score \u226520 on the Montgomery-Asberg Depression Rating Scale (MADRS)\n3. per SCID-5-RV interview, meet DSM-5 diagnostic criteria for at least one of the following: Major Depressive Disorder, Bipolar Disorder (I or II), Persistent Depressive Disorder, or Other Specified Depressive or Bipolar Disorder\n4. exhibit treatment resistance, defined as: failure to respond to \u22652 adequate trials of an FDA-approved antidepressant medication \\[per the Antidepressant Treatment History Form-Short Form (ATHF-SF)\\] within the current episode (for unipolar depression) and/or failure to respond to two adequate mood stabilizer treatment trials (for bipolar depression patients)\n5. be eligible and clinically enrolled for upcoming IV ketamine at one of our study clinics according to that clinic's standard intake procedures\n6. agree to maintain a stable schedule of concomitant psychiatric medications throughout the ketamine induction phase (minor adjustments to PRN meds and timing of meds are allowable), and for 4 weeks post-induction phase\n7. possess a level of judgment and understanding sufficient to agree to all procedures required by the protocol and must sign an informed consent document\n8. be willing and able to provide names and contact information for at least 1 additional emergency contact in the patient's proximal geographic area (in addition to the ketamine treatment team at the enrolling site)\n\nExclusion Criteria:\n\n1. Presence of current/acute psychosis, mania, moderate-severe substance/alcohol use disorder, or dementia, or a diagnosis of developmental disorder with significant language and/or intellectual impairment (e.g., autism spectrum disorder)\n2. Current/acute suicide risk with intent to act, defined as CSSRS past-week ideation score \u2265 4\n3. Mini-Mental State Exam (MMSE) \\< 24\n4. Current pregnancy or breastfeeding\n5. English reading level \\<5th grade as per WRAT-3 reading subtest Rationale: to ensure adequate reading comprehension for verbal ASAT/sham stimuli which are presented in English",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "maximumAge": "80 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Rebecca B Price, PhD",
                    "role": "CONTACT",
                    "phone": "412-383-2150",
                    "email": "canlab@pitt.edu"
                },
                {
                    "name": "Crystal Spotts, M.Ed.",
                    "role": "CONTACT",
                    "phone": "412-246-5764",
                    "email": "spottscr@upmc.edu"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Rebecca B Price, PhD",
                    "affiliation": "University of Pittsburgh",
                    "role": "PRINCIPAL_INVESTIGATOR"
                }
            ],
            "locations": [
                {
                    "facility": "Kaiser Foundation Research Institute, a division of Kaiser Foundation Hospitals",
                    "city": "Oakland",
                    "state": "California",
                    "zip": "94612",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Steven Hamilton, MD",
                            "role": "CONTACT",
                            "email": "Steven.P.Hamilton@kp.org"
                        },
                        {
                            "name": "Gabby Sanchez",
                            "role": "CONTACT",
                            "email": "Gabriela.X.Sanchez@kp.org"
                        },
                        {
                            "name": "Andrew Avins, MD",
                            "role": "SUB_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 37.80437,
                        "lon": -122.2708
                    }
                },
                {
                    "facility": "University of Illinois at Chicago",
                    "city": "Chicago",
                    "state": "Illinois",
                    "zip": "60612",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Alex Leow, MD",
                            "role": "CONTACT",
                            "email": "alexfeuillet@gmail.com"
                        },
                        {
                            "name": "Sarah Kabir",
                            "role": "CONTACT",
                            "email": "skabir4@uic.edu"
                        }
                    ],
                    "geoPoint": {
                        "lat": 41.85003,
                        "lon": -87.65005
                    }
                },
                {
                    "facility": "Baylor College of Medicine",
                    "city": "Houston",
                    "state": "Texas",
                    "zip": "77030",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Sanjay Mathew, MD",
                            "role": "CONTACT",
                            "email": "sjmathew@bcm.edu"
                        },
                        {
                            "name": "Julia Engelhardt",
                            "role": "CONTACT",
                            "email": "julia.engelhardt@bcm.edu"
                        }
                    ],
                    "geoPoint": {
                        "lat": 29.76328,
                        "lon": -95.36327
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "YES",
            "description": "Individual participant data that underlie the results will be shared with other researchers via the NIMH Data Archive (NDA) data repository.",
            "timeFrame": "Data will become available one year after study completion and will be available indefinitely.",
            "accessCriteria": "NDA access required.",
            "url": "https://nda.nih.gov/"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000003863",
                    "term": "Depression"
                }
            ],
            "ancestors": [
                {
                    "id": "D000001526",
                    "term": "Behavioral Symptoms"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M7058",
                    "name": "Depression",
                    "asFound": "Depression",
                    "relevance": "HIGH"
                },
                {
                    "id": "M7061",
                    "name": "Depressive Disorder",
                    "relevance": "LOW"
                },
                {
                    "id": "M4818",
                    "name": "Behavioral Symptoms",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BXM",
                    "name": "Behaviors and Mental Disorders"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                }
            ]
        },
        "interventionBrowseModule": {
            "browseLeaves": [
                {
                    "id": "M10674",
                    "name": "Ketamine",
                    "relevance": "LOW"
                },
                {
                    "id": "M4247",
                    "name": "Antidepressive Agents",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "Analg",
                    "name": "Analgesics"
                },
                {
                    "abbrev": "CNSDep",
                    "name": "Central Nervous System Depressants"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                },
                {
                    "abbrev": "PsychDr",
                    "name": "Psychotropic Drugs"
                }
            ]
        }
    },
    "hasResults": false
}